Alison S. Long

Insider Reports History

Location
Lexington, MA
Signature
/s/ Kamran Alam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alison S. Long:

Company Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. Director Common Stock 105,843 $245,555 $2.32 02 Jun 2025 Direct
Kaleido Biosciences, Inc. Chief Medical Officer Restricted Stock Units 125,000 14 Jan 2022 Direct
Taysha Gene Therapies, Inc. Director Stock Option (right to buy) 113,246 02 Jun 2025 Direct

Insider Reports Filed by Alison S. Long

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TSHA Taysha Gene Therapies, Inc. 02 Jun 2025 2 $0 4 Director 04 Jun 2025, 16:15
TSHA Taysha Gene Therapies, Inc. 29 May 2024 2 $0 4 Director 31 May 2024, 16:18
TSHA Taysha Gene Therapies, Inc. 01 Nov 2023 1 $0 4 Director 03 Nov 2023, 16:41
TSHA Taysha Gene Therapies, Inc. 01 Nov 2023 0 $0 3 Director 03 Nov 2023, 16:40
KLDO Kaleido Biosciences, Inc. 14 Jan 2022 2 $0 4 Chief Medical Officer 18 Jan 2022, 16:15
KLDO Kaleido Biosciences, Inc. 15 Dec 2021 2 $0 4 Chief Medical Officer 16 Dec 2021, 16:18
KLDO Kaleido Biosciences, Inc. 15 Dec 2021 0 $0 3 Chief Medical Officer 16 Dec 2021, 16:16